Anemia is a common finding in lymphoma. There are few data available regarding the erythropoietin (EPO) levels in conjunction with ferritin in lymphoma patients. We prospectively evaluated 55 patients diagnosed with malignant lymphoma during the period between November 2006 and March 2008 at King Abdullah University Teaching Hospital, Jordan. Our data showed that 74.4% of lymphoma patients were anemic. Furthermore, serum EPO and ferritin levels were higher in lymphoma patients compared with the healthy controls (P=0.001). The observed versus predicted EPO ratio showed also significantly higher levels in anemic lymphoma patients compared to healthy controls (p=0.03). There was an improvement in Hb level in lymphoma patients who were treated...
Anemia is a frequent sign in patients with diffuse large B-cell lymphoma (DLBCL) at diagnosis. We de...
Anemia is a frequent sign in patients with diffuse large B-cell lymphoma (DLBCL) at diagnosis. We de...
Previous phase I-II clinical trials have shown that recombinant human erythropoietin (rHuEpo) can am...
Introduction: Anemia is a common complication of malignant lymphomas, which could be a direct conseq...
Anaemia is a frequent complication of advanced chronic lymphocytic leukaemia (CLL) and several cytok...
The pathogenesis of the anemia of cancer involves the combination of a shortened erythrocyte surviva...
There are conflicting data about the effects of cisplatin on erythropoietin (EPO) response to anemia...
Anemia is a frequent sign in patients with diffuse large B-cell lymphoma (DLBCL) at diagnosis. We de...
BACKGROUND. Anaemia is a frequent finding in patients with cancer and may be due to different causes...
Anemia is a frequent sign in patients with diffuse large B cell lymphoma (DLBCL) at diagnosis. We de...
Anemia is a frequent clinical feature with adverse prognostic effects in patients with chronic lymph...
Anemia is a frequent sign in patients with diffuse large B-cell lymphoma (DLBCL) at diagnosis. We de...
Anemia is a frequent sign in patients with diffuse large B-cell lymphoma (DLBCL) at diagnosis. We de...
Anemia is a frequent sign in patients with diffuse large B-cell lymphoma (DLBCL) at diagnosis. We de...
Anemia is a frequent sign in patients with diffuse large B-cell lymphoma (DLBCL) at diagnosis. We de...
Anemia is a frequent sign in patients with diffuse large B-cell lymphoma (DLBCL) at diagnosis. We de...
Anemia is a frequent sign in patients with diffuse large B-cell lymphoma (DLBCL) at diagnosis. We de...
Previous phase I-II clinical trials have shown that recombinant human erythropoietin (rHuEpo) can am...
Introduction: Anemia is a common complication of malignant lymphomas, which could be a direct conseq...
Anaemia is a frequent complication of advanced chronic lymphocytic leukaemia (CLL) and several cytok...
The pathogenesis of the anemia of cancer involves the combination of a shortened erythrocyte surviva...
There are conflicting data about the effects of cisplatin on erythropoietin (EPO) response to anemia...
Anemia is a frequent sign in patients with diffuse large B-cell lymphoma (DLBCL) at diagnosis. We de...
BACKGROUND. Anaemia is a frequent finding in patients with cancer and may be due to different causes...
Anemia is a frequent sign in patients with diffuse large B cell lymphoma (DLBCL) at diagnosis. We de...
Anemia is a frequent clinical feature with adverse prognostic effects in patients with chronic lymph...
Anemia is a frequent sign in patients with diffuse large B-cell lymphoma (DLBCL) at diagnosis. We de...
Anemia is a frequent sign in patients with diffuse large B-cell lymphoma (DLBCL) at diagnosis. We de...
Anemia is a frequent sign in patients with diffuse large B-cell lymphoma (DLBCL) at diagnosis. We de...
Anemia is a frequent sign in patients with diffuse large B-cell lymphoma (DLBCL) at diagnosis. We de...
Anemia is a frequent sign in patients with diffuse large B-cell lymphoma (DLBCL) at diagnosis. We de...
Anemia is a frequent sign in patients with diffuse large B-cell lymphoma (DLBCL) at diagnosis. We de...
Previous phase I-II clinical trials have shown that recombinant human erythropoietin (rHuEpo) can am...